
Sign up to save your podcasts
Or
Ella Al-Shamahi meets two women on the frontline in the fight against malaria.
Dr Ify Aniebo is from Nigeria, the country worst hit by malaria. She is an Associate professor with the African Centre of Excellence for Genomics of Infectious Diseases, where she works to improve the country's response to drug resistance and malarial transmission.
Dr Mehreen Datoo is a clinical lecturer in Infectious Diseases at the University of Oxford and she’s on the team that developed the R21/Matrix-M, the WHO approved vaccine that will be rolled out across Africa in 2024.
Produced by Alice Gioia, Emily Naylor and Jane Thurlow.
(Image: (L) Dr Mehreen Datoo, courtesy of Dr Mehreen Datoo. (R) Dr Ify Aniebo, courtesy Dr Ify Aniebo.)
4.5
6969 ratings
Ella Al-Shamahi meets two women on the frontline in the fight against malaria.
Dr Ify Aniebo is from Nigeria, the country worst hit by malaria. She is an Associate professor with the African Centre of Excellence for Genomics of Infectious Diseases, where she works to improve the country's response to drug resistance and malarial transmission.
Dr Mehreen Datoo is a clinical lecturer in Infectious Diseases at the University of Oxford and she’s on the team that developed the R21/Matrix-M, the WHO approved vaccine that will be rolled out across Africa in 2024.
Produced by Alice Gioia, Emily Naylor and Jane Thurlow.
(Image: (L) Dr Mehreen Datoo, courtesy of Dr Mehreen Datoo. (R) Dr Ify Aniebo, courtesy Dr Ify Aniebo.)
5,453 Listeners
1,801 Listeners
7,688 Listeners
526 Listeners
1,800 Listeners
1,084 Listeners
1,937 Listeners
1,053 Listeners
394 Listeners
274 Listeners
527 Listeners
328 Listeners
264 Listeners
4,193 Listeners
729 Listeners
3,196 Listeners
61 Listeners
104 Listeners
22 Listeners
14 Listeners
17 Listeners
50 Listeners
118 Listeners